Medpace Holdings, Inc. Stock 12‑Month Price Target Raised to $508.55, Implies 4% Downside

• According to estimates from 11 analysts, Medpace Holdings, Inc. stock's average price target has risen from $485.36 to $508.55, with forecasts ranging from $419 to $600 per share
• Based on the Jul. 22 closing price, the updated target implies approximately 4% potential downside
• Consensus rating remains at “Hold” across 15 covering analysts, with 3 Buys, 11 Holds and 1 Sells

Explore more price target data and ratings for Medpace Holdings, Inc. on the , and track all previous and future analyst recommendations for Medpace Holdings, Inc. in the dedicated .

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.